Literature DB >> 11299758

Adenovirus-mediated suicide gene transfer to small cell lung carcinoma using a tumor-specific promoter.

E Morimoto1, N Inase, S Mlyake, Y Yoshizawa.   

Abstract

The gastrin-releasing peptide (GRP) is expressed in most types of small cell lung carcinoma (SCLC) and the GRP promoter is thought to be potentially useful for tumor-specific expression of the suicide gene in SCLC. We constructed an adenovirus containing the herpes simplex thymidine kinase suicide gene driven by the GRP promoter (AdGRP-TK) and transfected it into GRP-expressing SCLC cells (SBC5) to confer sensitivity to ganciclovir (GCV). After infection with AdGRP-TK, SBC5 cells became more sensitive to GCV in vitro. In nude mice, a subcutaneously-inoculated tumor of SBC5 cells infected with AdGRP-TK in advance regressed completely after intraperitoneal administration of GCV. These results suggest that adenovirus-mediated gene transfer of the suicide gene followed by pro-drug treatment may be applicable to SCLC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11299758

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Study on the effect of BMSCs-EGFP-tk as mediator of HSV1-tk/GCV suicide gene therapy directed against A549 in vitro.

Authors:  Kun Yang; Wen-Gui Xu; Yong-Zhe Liu; Xiang-Rui Meng; Peng Chen; Li-Chuan Wu
Journal:  Int J Clin Exp Med       Date:  2014-09-15

2.  Targeted cytosine deaminase-uracil phosphoribosyl transferase suicide gene therapy induces small cell lung cancer-specific cytotoxicity and tumor growth delay.

Authors:  Camilla L Christensen; Torben Gjetting; Thomas T Poulsen; Frederik Cramer; Jack A Roth; Hans S Poulsen
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

3.  Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene.

Authors:  Li-Zong Shen; Wen-Xi Wu; De-Hua Xu; Zhong-Cheng Zheng; Xin-Yuan Liu; Qiang Ding; Yi-Bing Hua; Kun Yao
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

4.  Development of a therapeutic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity enhancement.

Authors:  Peter Nagi; Selwyn M Vickers; Julia Davydova; Yasuo Adachi; Koichi Takayama; Shannon Barker; Victor Krasnykh; David T Curiel; Masato Yamamoto
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

5.  Transcriptional Targeting in Cancer Gene Therapy.

Authors:  Tracy Robson; David G. Hirst
Journal:  J Biomed Biotechnol       Date:  2003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.